Skip to main content

Notice

We are in the process of rolling out a soft launch of the RDA website, which includes a new member platform. Existing RDA members PLEASE REACTIVATE YOUR ACCOUNT using this link: https://rda-login.wicketcloud.com/users/confirmation. Visitors may encounter functionality issues with group pages, navigation, missing content, broken links, etc. As you explore the new site, please provide your feedback using the UserSnap tool on the bottom right corner of each page. Thank you for your understanding and support as we work through all issues as quickly as possible. Stay updated about upcoming features and functionalities: https://www.rd-alliance.org/rda-web-platform-upcoming-features-and-functionalities/

#130032

> Christopher
> Thanks for the interest
> I guess it depends where you are coming from
> Medical research is highly regulated and institutionalised with strong
> influence of large pharmaceuticals
> as we know- what I do is save a life if I can – often mine – in situations
> where there is no other option than take a risk of experimental approaches
> Maybe this community is made up of geeks or medical professionals, I am a
> field worker
> and do what I have to
> I have updated the protocol BTW – look forward to be discussing offlist
> how to possibly
> collaborate
>
> https://www.protocols.io/view/emergency-medicine-em-protocol-for-the-all
>
> Thanks for interst
> PDM
>
> On Thu, Apr 2, 2020 at 9:22 PM Christopher D. Harrison <
> ***@***.***> wrote:
>
>> Dr Paola Di Maio,
>> Thanks for the information and understanding of this situation.
>> Unfortunately I really do not think the rest of the RDA community
>> understands all the restrictions and red tape involved in medical research,
>> sigh. I am going to ask my community for interested in joining you in a
>> collaboration. I do have collaborators with lab facilities and I will
>> get back to you soon with interested parties.
>>
>> -C
>>
>>
>>
>>
>> On 4/2/20 12:55 AM, ***@***.*** wrote:
>>
>> Harrison
>>
>> Thanks for sharing your concerns
>>
>> I am also a systems engineer doubling as anything that is needed,
>> now in clinical emergency
>>
>> I am temporarily bypassing restrictions publishing protocols and
>> hopefully soon some results here
>> https://protocols.io/share/DfVgOaP
>>
>> Here is one of my protocols for EM treatment of covid
>>
>> https://www.protocols.io/view/emergency-medicine-em-protocol-for-the-all
>>
>>
>> I am looking for trial partners with Lab facilities for a clinical study
>>
>> Let me know if you or others are interested in a collaboration
>>
>> Dr Paola Di Maio
>>
>>
>>
>>
>> On Thu, Apr 2, 2020 at 9:01 AM harrison via RDA-COVID19 <
>> ***@***.***-groups.org> wrote:
>>
>>> Hi all,
>>>
>>> I have recently identified an area which might be of more urgent need
>>> the research datasets. Currently our institution is trying to obtain
>>> something called IRB (Institutional Review Board) approval for COVID19
>>> research data. Each institution who conducts medial research in the USA
>>> needs an IRB to conduct research but some IRB’s are move more quickly
>>> then others. An IRB’s goal is to protect patients privacy and rights
>>> and providing a method to review ethical use a study. Applying to a
>>> IRB is typically a timely endeavor and is often a back and forth between
>>> a researcher and the IRB until a protocol for a study is established.
>>> The interesting thing about IRB’s is one institutional IRB can be used
>>> by other institutions if they are part of the study. It I believe a
>>> clearing house for IRB established studies would be greatly help the
>>> community.
>>>
>>> Additionally, a method for review of computational infrastructure and
>>> security practices, and by proxy a chain of trust to who is responsible
>>> for data security at a given institution would also be very helpful.
>>> Knowing who is able to secure and process sensitive data is very
>>> useful. For example, I know the department of Biostatistics and
>>> Medical Informatics at the University of Wisconsin – Madison is a
>>> Medically covered entity and can run analysis of HIPAA protected data.
>>> I also happen to run the 2800CPU core cluster for this department. So
>>> having a collaborator within this department would likely be helpful, I
>>> know other departments like ours exist so having a list of people to
>>> collaborate with would likely also be of use.
>>>
>>> Having worked in this field, I know it takes time to obtain
>>> de-identified data for use by the general public. I have worked with
>>> researchers who have taken 2+ years obtaining data (IRB + honest broker
>>> de-identify steps), which is part of the reason medical research is so
>>> slow.
>>>
>>>
>>> Thoughts,
>>> -C
>>>
>>>
>>> —
>>> Christopher Harrison
>>> Systems Engineer
>>> Department of Biostatistics & Medical Informatics
>>> University of Wisconsin School of Medicine and Public Health
>>> J4/503 CSC, Box 4675
>>> 600 Highland Avenue
>>> Madison, WI 53792-4675
>>> 608.3476.6967
>>>
>>>
>>> —
>>> Full post:
>>> https://www.rd-alliance.org/group/rda-covid19/post/health-data-and-irbs
>>> Manage my subscriptions: https://www.rd-alliance.org/mailinglist
>>> Stop emails for this post:
>>> https://www.rd-alliance.org/mailinglist/unsubscribe/68906
>>>
>>>
>> —
>> Christopher Harrison
>> Systems Engineer
>> Department of Biostatistics & Medical Informatics
>> University of Wisconsin School of Medicine and Public Health
>> J4/503 CSC, Box 4675
>> 600 Highland Avenue
>> Madison, WI 53792-4675
>> 608.3476.6967
>>
>>